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Renal handling of cationic and anionic small proteins: Experiments in
intact rats. C. Bianchi, C. Donadio, G. Tramonti, I. Auner, P. Lorii:,,
G. Deleide, F. Lunghi, P. Salvadori: Nefrologia Medica, Clin. .'iled. 2,
University of Pisa; Fisiologia Clin. CNR, Pisa; and Sorin Biomedica,
Saluggia VC, Italy. The renal handling of four low molecular wt (mw)
proteins, 3 cationic and I anionic [lysozyme (LYS), mw 14,300 p1 11.0;
cytochrome C (CYT), mw 12,400 p1 10.6; aprotinin (APR), mw 6,500 p1
10.5; recombinant alpha-2a interferon (INT), mw 19,000 p1 6.21, was
studied in 174 Sprague-Dawley, adult male rats. All the experiments
were performed in intact animals after i.v. injection of proteins labelled
with 131J Distribution studies, carried out by total body scan, showed
major kidney accumulation of all the proteins. The time-course curves
of renal radioactivity were recorded by external counting to determine
time of highest kidney radioactivity (peak-time) and decrease of kidney
radioactivity in the 10 mm after peak-time (percent of peak radioactiv-
ity).
Number of rats
Renal curves
Peak-time
mm
Percent
decrease
LYS
CYT
APR
INT
12
9
9
12
19.8 2.5 5D
10.9 0.8
93.9 21.6
12.0 0.7
3.2 1.4
17.6 4.3
0.1 1.7
19.8 3.5
The radioactivity of kidney, urine and liver (percent of the injected dose)
was measured in animals sacrificed at the peak-time of each protein.
Number of rats
Peak-time radioactivity
Kidney Urine Liver
LYS
CYT
APR
INT
18
21
17
19
28.9 3.5 SD
30.8 3.5
49.6 7.6
40.8 7.1
0.4 0.2
0.5 0.2
0.8 0.5
1.0 0.7
9.8
14.8
6.4
7.1
1.5
1.6
1.5
1.5
These results indicate that: 1) all the 4 low mw proteins studied, both
cationic and anionic, are handled mainly by the kidney where they are
largely accumulated, with minimal excretion in the urine; 2) their renal
peak-time kidney uptake and release from the kidney are definitely
different.
Pharmacokinetics of pyrazinamide and pyrazinoic acid in patients with
chronic renal failure (CRF) who are on hemodialysis (HD). G. Stamata-
kis, H. Fessi, R. Farinotti, C. Montès, J.-H. Trouvin, S. Kenouch, and
J.Ph. Méry, Service de Nephrologie Ct Service Pharmaceutique who
are, Hôpita! Bichat, Paris, France. Pyrazinamide (PYR), commonly
used in the treatment of tuberculosis, is prevalent in patients with CRF.
In normal individuals, PYR is excreted primarily by the kidneys, mainly
in the form of pyrazinoic acid (PZA), an active metabolite which is
formed by hydrolysis in the liver. Pharmakocinetics of PYR and PZA
were studied after ingestion of a single dose of 1 g of PYR (Pirilène®)
in 10 male normal volunteers (N) and in 10 male CRF patients on HD.
Plasma levels of PYR and PZA were measured by HPLC : a) in CRF
patients in the interval between the end of a HD session (ingestion of
PYR) and the beginning of the following session (10 measurements; b)
in N during the 48 hours following ingestion of PYR (12 measurements).
The following parameters were derived by calculation: Tmax, Cmax, T
apparent total clearance (Cl), volume of distribution (Vd), and area
under the curve (AUC). Results are means.
T C
,ng liter
T"2
hr
PYR
N
HD
PZA
N
HD
1.5
1.8
4.2
6.8
19.2
18.88
2.67 1 c
7.83 5
9.53 1 b
43.05 J
12.6 a
22.48
Clliter hr kg Vdliter kg AUCmg . liter hr
PYR
N
HD
PZA
N
HD
0.05
0.04
—
0.73
1.62
—
267.9 a
613.3
4991b
308.15
Conclusions. These results show that PZA and not PYR accumulates in
CRF. This accumulation is more likely to be the consequence of
diminished renal excretion of PZA than of increased catabolism of
PYR. Insofar as it has not been ruled out that toxic reactions to PYR are
due to PZA, it seems reasonable to use reduced doses of PYR in CRF.
Renal clearance of endogenous atrial natriuretic peptide in dogs. C.
Deray, G. Maistre, P. Cacoub, C. Barthélémy, A. Carayon, A.
Baumelou, C. Jacobs, Departments of Nephrology and Biochemistry,
Hôpital de la Pitié Salpétrière, Paris, France. Although the plasma half
life of exogenous ANP has been estimated as 2.5 to 3 mm, the clearance
of endogenous ANP by regional circulation has not been yet deter-
mined. During its passage through the human kidney about 50% of
endogenous ANP disappears from the plasma, thus suggesting that the
kidney contributes to ANP clearance. We measured the renal clearance
of endogenous ANP in 7 male mongrel dogs. Renal blood flow was
measured with an electromagnetic flow probe. Simultaneous renal vein
and aortic plasma ANP samples were analyzed by radioimmunoassay to
determine renal extraction and calculate renal clearance. Renal blood
flow was 127.4 13.4 mI/mm, mean SEM (range 80 to 195 mI/mm). All
dogs demonstrated a fall in plasma ANP concentration between the
aorta (28.6 4.5 pg/mI, range 17 to 50 pg/mI) and the renal vein (14.2
1.7 pg/mI, range 8 to 26 pglml; (P < 0.01). The renal extraction ratio of
endogenous ANP averaged 51.3 3.7% (range 32 to 60%) and mean
renal clearance was 38.2 5.2 mI/mm (range 20.5 to 61.1 mI/mm). ANP
renal clearance correlated with renal blood flow (r = 0.9, P = 0.006, y
= 0.34 x —5.54). Our data show that in dogs renal extraction contrib-
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utes to the clearance of endogenous ANP. Increased plasma ANP
concentrations are observed in patients with chronic renal failure.
Moreover, we have previously shown that a significant correlation
exists between serum creatinine and plasma ANP levels, We suggest
that altered ANP clearance may contribute to the increased ANP
plasma levels observed in patients with chronic renal failure.
Food antigens and IgA mesangial glomerulonephritis. U. Rostoker, P.
Lang, M.A. Pech, J. Laurent, f.M. Heslan, U. Lagrue Service de
Ndphrologie, INSERM U 139, Association Claude Bernard, Hdpital
Henri Mondor, Crdteil, France, The pathogenesis of IgA mesangial
glomerulonephritis (IgA ON) remains controversial, but most evidence
suggests that glomerular damage results from the deposition within the
kidney of IgA circulating immune complexes. It has been suggested that
increased IgA synthesis following antigenic stimulation at mucosal
surfaces may contribute to the immune complex formation. A possible
role of food antigens needs to be investigated. Detection of IgA
antibodies towards 8 dietetary antigens (gliadin, egg, lysozyme, oval-
bumin, ovomucoid, BSA, Blactoglobulin, casein, alphalactalbumin)
was performed using indirect ELISA technic in 17 IgA ON patients
having permanent proteinuria and microscopic hematuria, and in It
paired controls. Results were compared using the nonparametric Mann
and Whitney test. Correlations were studied by the nonparametrie
Spearman test. The Yates chi square test was used to compare the
number of patients with nonsevere and severe IgA GN (creatinine >
150 Mmol/liter) that had high levels of IgA antigliadin antibodies and an
upper value of IgA towards 3 or more dietetary antigens. The study of
the giiadin epitopes recognized by the IgA and tgG of patients and
controls was performed by Western blot technique following an
isotachophoresis of the gliadins. IgA ON patients exhibited significantly
higher levels of IgA antibody to gliadin, lysozyme, ovalbumine, BSA
and alphalactalbumin. Of the patients 17.6% reacted to 2 food antigens,
52.9% to 3 or 4 antigens and 29.4% to ,Jf more dietetary antigens. The
level and the number of IgA against food antigens was not correlated
with the severity of the disease. The Western blot revealed a high
variability of the gliadin fractions recognized by IgA and tgG antibodies
in both IgA UN patients and normal adults; no specific pattern could be
related to IgA ON. This study suggests that the IgA UN overproduce
IgA antibodies to environmental antigens. Further studies are required
to characterize an eventual pathological role of this overproduction.
Natural anticoagulant proteins in the adult nephrotic syndrome (NS).
U. Rostoker, P. Lang, T. Gadela-Parente, M.A. Pech, M. Gouault-
Heilmann, M. Levent, L. Intrator, A. Branellec, U. Lagrue, Service
Nephrologie, Laboratoire Hematologie, INSERM U. 139, Association
Claude Bernard, Hdpital Henri Mondor, Créteil, France. Since throm-
boembolic events remain one of the most serious problems complicat-
ing adult NS, protein C-protein S and antithrombin II (AT III) natural
anticoagulant systems were evaluated in 23 adult proteinuric patients, 7
without and 16 with NS of various types. The control group consisted
of 18 healthy adult volunteers. Total protein S antigen (TPS Ag) and
free protein S antigen (FPS Ag) were measured by Laurel Rocket
electrophoresis (LRE). Protein S complexed to C4 BP were precipitated
by PEG, and FPS Ag was evaluated in the supernatant. Urinary protein
S was assayed on concentrated urine by ELISA. C4 BP was measured
by LRE; protein C antigen (PC Ag), AT HI biological activity were
assayed respectively by ELISA and the amidolytic method. Other
parameters were measured by routine techniques. Results were com-
pared by the nonparametric Mann-Whitney test; correlations were
studied by the Spearman test. PC Ag was significantly higher in
proteinuric patients both without and with NS. TPS Ag was signifi-
cantly higher only in mild NS whereas FPS Ag did not differ between
proteinuric patients and controls. Urinary excretion of protein S was
found in 9 of 10 patients. C4 BP was significantly increased in mild and
moderate NS. No statistical difference could be found for AT III. A
negative correlation (r 0.45, P C0.05) was observed between EPS Ag
and the ratio C4 BP/TPS Ag. Nevertheless, 2 NS patients exhibited a
decrease of FPS Ag (respectively 0.34 U/mI and 0.35 U/mI; lower limit
of controls (LLC) 0.64 U/mI). Three patients had low AT III levels
(respectively 0.60 U/mi, 0.40 U/mi, 0.60 U/mI; LLC 0.85 U/mi),
whereas one patient had decreased PC Ag (0.63 U/mI; LLC 0.74 U/mi).
Two patients with NS suffered from renal vein thrombosis; they
displayed either a decrease of FPS Ag (0.35 U/ml) with high level of C4
BP (1.5 U/mI) associated with AT III deficiency (0.48 U/mI; patient n°
1) or a decrease of PC Ag (patient n° 2 : PC Ag 0.63 U/mI). Such results
suggest that a decrease of FPS Ag and PC Ag levels in some patients
may contribute to the hypercoagulability state of NS and favor throm-
boembolic complications.
Influence of age on fl2-microglobulin amyloidosls in patients undergo-
ing long-term hemodialysis. M. Benzakour, f.P. Charmes, M. RincE, C.
Leroux-Robert, Service de Néphrologie, Hopital Universitaire
Dupuytren, Limoges, France. Recently 32-microglobulin (thm)
amyloidosis has been identified as a new form of amyloidosis. Its
pathogenesis is not yet well understood. To demonstrate the possible
role of a clinical or biological factor, we studied 36 hemodialysis
patients whose dialysis duration was over 8 years. Ten had joint
amyloidosis, of whom 6 patients had amyloid protein identified as
/32-microglobulin. Twenty-six patients had no evidence of joint
amyloidosis. We did not find any correlation between these two groups
in regard to their initial nephropathies, creatinine, urea calcium and
phosphate levels, hyperparathyroidism, aluminium intoxication, serum
levels of 132m, duration of hemodialysis especially with cuprophane
membranes, dialysate, and frequency of histocompatibility antigens.
The average age of patients with joint amyloidosis (61 4.1) was
significantly higher than patients without amyloidosis (43.8 8.5),
indicating that the risk of joint amyloidosis is higher in older hemodi-
alysis patients. Moreover, classical joint amyloidosis is well known in
the elderly. Factors responsible for its pathogenesis might be the same
in dialysis amyloidosis.
Importance of proteinaceous material found in kidney stones in chron-
ically hemodlalyzed patients. M. Rincé, M. Benzakour, J.P. Char,nes,
P. Peyronnet, C. Moesch, C. Leroux-Robert, Service de Néphrologie,
HOpital Universitaire Dupuytren, Limoges, France. A search for kid-
ney stones was undertaken in 46 chronically hemodialyzed patients by
obtaining plain abdominal films with tomography. Rounded, often
multiple kidney stones were discovered in 26 patients (56%); no stone
exceeded 5 mm in diameter. Five patients passed 13 stones, which were
shown to be composed almost exclusively of calcium oxalate
monohydrate (wheweilite) and proteins by infra-red spectrophotometry
analysis. These proteins represented 5 to 99% of the stone's dry weight.
A direct relationship was noted between the incidence of kidney stones
and the duration of chronic hemodialysis. It has recently been shown
that the protein matrix of these stones is composed of proteolytic
fragments of j3microglobulin. We conclude that kidney stones in
chronically hemodialyzed patients differ from those in the general
population by their frequency and composition. It appears that protein-
aceous material may play an important lithogenic role, and that it is
probably related to another complication of chronic hemodialysis:
/32-microglobulin amyloidosis.
Erosive osteoarthropathy associated to -mlcroglobulin amyloidosis in
a uremic patient exclusively treated by long-term hemofiltration with
blocompatible membranes. H. Renaud, A. Fournier, M. El Esper, Ph.
Moriniere, .JL Sebert, CHU Amiens, Service de NEphrologie, France.
The case of a cervical erosive multifocal spondylarthropathy associated
with a suscotyloidal lacuna containing /32-microglobulin amyloidosis is
reported; it is the first case to be reported in a uremic patient who has
been exclusively treated by long-term hemofiltration with biocompat-
ible and permeable membrane, such as the polyacrylonitrile AN 69
membrane and polyamide membrane. This complication occurred par-
adoxically earlier than in hemodialysis with cuprophan since the first
irregularities of the cervical vertebral plates were seen only after 4 years
of hemofiltration. Therefore, factors other than the bioincompatibility
and the impermeability of the membrane to /3rmicroglobulia should be
looked for, such as pyrogenic reactions, due to the substitution fluid
leading to greater expression of /3rmicroglobulia on the lymphocytes,
and the mechanical stress of the lymphocytes due to the higher
transmembrane pressure gradient necessary for high ultrafiltration in
the hemofiltration technique, leading to greater shedding of /3rmicr-
oglobulin.
Pyelonephrltis and acute renal failure (ARF): Unfavorahle evolution in
3 alcoholic patients because of a round cell interstitial nephritls. R.
Makdassi, B. Coevoet, J.L. Schmit, H. Renaud, f. Brasseur, R.
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Demontis, A. Fournier, Chu Amiens, Chg de St Quentin, France. ARF
may occur with acute pyelonephritis, especially when it is complicated
by a septicemia. Usually its evolution is favorable when infection is
controlled. It is also known that alcoholism favors FL. coli septicemia.
Nevertheless, irreversible evolution of acute pyelonephritis in alcoholic
patients has rarely been reported. We report 3 such cases observed
during the last two years: 2 males and 1 female, aged from 38 to 51
years, whose alcoholism was admitted by all and confirmed by
hepathomegaly, increased MGV and .GT. Furthermore, hepatic
steatosis was diagnosed by sonography in one case and by a biopsy in
the second case. On admission all patients were febrile with a E. coli
urinary infection. Two of them, had a positive FL. coli hemoculture.
Increased renal volume without dilation of the excretory cavities were
observed on the EU and the CAT scan. Septic syndrome was rapidly
controlled by antibiotherapy, but I month after discontinuation of the
antibiotherapy a renal biopsy was performed because of the persistance
of altered renal function and the presence of leucocyturia without
bacteriuria. It revealed a round cell interstitial nephritis in all cases. No
allergic phenomenon of drug was observed in any of our patients and no
deep focal infection was found. The evolution was irreversible and led
in one case to terminal renal failure and in another case to chronic renal
failure with 200 jmoUliter of serum creatinine. In the third case, which
received a corticotherapy during 3 months, normal renal function was
recovered but with a right renal atrophy at the EU and CAT scan.
Conclusion. The severity of the evolution of pyelonephntis in these
cases is probably in relation to the alcoholism, which may disturb the
immunological response. The third observation, suggests that cortico-
therapy may be beneficially added when infection is controlled.
Effects of ketoanalogs on nitrogen and phosphocalcic metabolism in
dialyzed patients A prospective randomized and crossover study. V.
Bouche, M.D. Mahmoud, PH. Collin, Service d'Hémodia/yse CH
Cholet, 1 rue Marengo, Cholet, France. The short term effects of a low
(RPP, 0.4 g/kg/day) and a normal (RN: 1 g/kg/day) protein diet supple-
mented by calcium salts of ketoanalogs (CA) (200 mg/kg/day) were
compared in 15 chronic dialyzed patients for 15 days. The CA were well
tolerated but CA.RPP was accompanied by a caloric diminution of 12%(P = 0.001) and a albumin reduction of 5% (P = 0.004). Blood urea
nitrogen was reduced by 32% (P = 0.001) with CA.RPP. Creatininemia
was not modified by CA.RPP or CA.RN. Blood phosphorus (Ph) and
the parathormone (PTH) were respectively reduced by 29% (P = 0.001)
and 27% (P = 0.008) with CA.RPP, and by 15% (P = 0.03) and 18% (P
= 0.006) with CA.RN. Calcemia was increased about 9% (P = 0.002) by
both treatments. There was no significant difference between the two
treatments. Thus CA can reduce Ph and PTH without the need for a
restricted protein diet, which may be accompanied by complications
during long-term utilization.
indirect clinical evidence that la(OH) vitamin D3 increases the intes-
tinal absorption of aluminium. Demontis R. Reissi D, Noel C. Fournier
A, Leflon P. Brasseur J, Coevoet B, CHU A miens et Lille, Centre
Hospitalier Saint Quentin, France. In a former study we have shown
that 1 a(OH) vitamin D3 given to 16 hemodialyzed patients taking
Al(OH)3 at a constant dose increased their plasma concentrations of
aluminium (C/in Nephrol 26:146—149, 1986). In order to choose between
2 possible mechanisms explaining this increase (increased intestinal
absorption or decreased tissue storage of aluminium), we have, in the
present study given I a(OH)3 at the same dose of (6 sg per week) and
during the same duration (4 weeks) to 15 stable hemodialyzed patients
after their Al(OH)3 has been discontinued for 6 weeks. Under Al(OH)3
treatment they had a mean plasma aluminium (2.33 2.36 smol/liter)
which was lower, but not significantly different from that of the patients
from their former study (1.23 0.25 smo1Iliter). After A1(OH)3
discontinuation, plasma aluminium (measured by inducted coupled
plasma emission spectrometry) decreased significantly as soon as the
second week of the control period (1.39 smol/ liter). The decrease was
maintained in plateau throughout the 5 weeks of the control period (1.38
pinol/liter) the 4 weeks of la(OH)Vit D3 administration (1.40 prnollliter)
and the 8 weeks of the post la(OH)3 period (1.22 mol/liter). Plasma
calcium and phosphate concentrations increased significantly with
la(OH)3 and decreased thereafter, suggesting biological activity of
la(OH)3. Conclusion. Since la(OH)3 increases plasma aluminium in
hemodialyzed patients only when they are simultaneously taking
Al(0H3), it is suggested that this increase is explained by an increase of
intestinal absorption of aluminium and not by a tissue redistribution of
aluminium.
Endotoxin (ET) induces tumor necrosis factor (TNF) synthesis by
cultured rat mesangial cells (MC). L. Baud, J. Perez, R. Ardaillou,
INSERM 64, Hôpital Tenon, Paris, France. TNF is a cytokin which is
produced by mononuclear phagocytes upon activation by ET and
various other stimuli. During nephrotoxic serum nephritis, infiltration
of glomeruli by monocyte-macrophages is associated with production of
TNF. The present study was designed to determine if MC could also
contribute to glomerular TNF production. MC were exposed for 16 hr
to increasing concentrations (0.1 to 10 j.g/ml) of ET (E. co/i lipopoly-
saccharide), and TNF activity in the medium was monitored using the
L929 fibroblast lytic assay. TNF production was first apparent at 0.1
sg/ml and increased for concentrations in the range of 1 to 10 sgIml.
With 10 g/ml, TNF activity reached 121.9 34.9 U/mI (mean SEM,
N = 5). ET also caused a dose-dependent increase in prostaglandin
(PG) E2 synthesis by MC. Compared with basal synthesis, MC incu-
bated for 16 hr with 10 sg/ml ET produced 17.4-fold more PGE2. PGE2
acted in a feedback manner to regulate the production of TNF since : (i)
ET-induced TNF production was increased (x = 1.91 0.28; n = 3)
after the addition of indomethacin (1 M); (ii) addition of PGE2
promoted a dose-dependent decrease of ET-induced TNF synthesis (x
= 0.21 0.06 at 0.1 M PGE2; N = 3). Addition of dibutyryl cyclic
AMP (0.1 tM to 0.1 mM) caused similar decreases of ET-induced TNF
synthesis, suggesting that the inhibitory effect of PGE2 could be
mediated via cyclic AMP production. In conclusion, TNF is released by
MC upon stimulation by ET and its synthesis is regulated by PGE2 and
cyclic AMP. TNF can thus be a potentially important mediator in the
inflammatory process during glomerulonephritis.
Necrotizing glomerulonephritis and acute renal failure in a patient with
rheumatoid arthritis. P. Troll jet, R. Cahen, Ch. Chazot, B. Francois,
Service de Nephrologie, Centre Hospitalier Lyon-Sud, Pierre-Bénite,
France. Rheumatoid arthritis (RA) is not infrequently complicated by a
spectrum of renal disorders (amyloidosis, interstitial nephritis, mem-
branous nephropathy). Necrotizing glomerulonephritis (GN) is most
unusual. We report a patient with RA and acute renal failure related to
necrotizing GN. A 63-year-old man had been suffering from mild but
definite RA for 4 years. He had never received gold or penicillamine
therapy. Mild proteinuria and microscopic hematuria were first dis-
closed in March 1987. During the next 6 weeks proteinuria became
nephrotic and serum creatinine increased from 91 to 961 amol/liter
without oliguria. Further evaluation showed normal serum complement
level, absence of anti-n DNA antibodies and presence of rheumatoid
factors and mixed cryoglobulinemia (IgG + 1gM). The search for
anti-neutrophil cytoplasm antibodies was negative. Renal biopsy
showed on light microscopy global or segmental exudative epithelial
proliferation and fibrinoid necrosis in the 12 examined glomeruli. No
vascular lesions were seen. Immunofluorescence study detected only
prominent glomerular deposits of fibrinogen. Two hemodialysis ses-
sions were performed. With a treatment including steroids (750 mg/3
then 1 mg/kg/day), cyclophosphamide (2 mg/kg/day), and 11 plasma
exchanges serum creatinine decreased to 260 smoUliter. Necrotizing
glomerulonephritis in RA patients has been infrequently reported. In
contrast to that of Kuznetsky (Clin Nephrol 26:257), our case occurred
in a patient with mild RA and in the absence of any prior treatment with
penicillamine. Dramatic improvement in renal function may be
achieved by aggressive immunodepressive therapy.
A new cause of epimembranous glomerulopathy: Argyria. N. Chen, M.
Rainfray, P. Ca/lard, G. Messier, A. Meyrier, Hôpital Avicenne 93 009
Bobigny, Hôpital Jean-Verdier, Bondy, France. A 77-year-old man
developed nephrotic syndrome with normal renal function and no
abnormalities of the urinary sediment. He exhibited faint cutaneous
discoloration with a slate-like sheen. Percutaneous renal biopsy yielded
a sample of renal tissue which had an extraordinary black hue. By light
microscopy, dense granular bodies with a diameter in the order of I
micrometer were scattered along all glomerular basement membranes,
tubular basement membranes and within the interstitium of the renal
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medulla. By immunofluorescence, epimembranous IgO deposits were
found with a typical appearance of epimembranous glomerulopathy. By
electron microscopy, granular bodies with a metallic appearance were
seen within the glomerular basement membranes and, to a lesser
degree, within the mesangial matrix, but were not present within the
epimembranous deposits. By X-ray diffraction, the nodular deposits
were identified as composed of silver. The source of silver intoxication
was determined to be self-administered treatment by throat spray
containing silver. The measurements of silver concentrations in blood
(960 nmollliter), in urine (178 nmol/liter) and in hair (12.7 mg/kg)
confirmed the severity of metal overload. Screening of the literature
since 1954 found only 3 cases of renal argyria, including 2 with
nephrotic syndrome, but none with epimembranous glomerulopathy.
The interest of this observation is not limited to the fact that it is unique.
This clinical case confirms experimental findings in the animal on the
incorporation of silver within glomerular basement membranes. It also
shows that, similarly to experimental mercury intoxication in Brown
Norway rats, the same heavy metal may elicit differing renal lesions.
We also ralse the hypothesis that in our patient silver determined the
release of some constituent of the glomerular basement membrane
which became antigenic, and was in turn responsible for the epimem-
branous deposits.
Familial cases of Berger's disease or of Berger's disease and 1-lenoch,
Schonlein purpura. French Cooperative Group of the Society of
Nephrology, M. Levy, INSERM U. 155, Château de Longchamp, Bois
de Boulogne, Paris, France. In Berger's disease (BD), both the
reported familial cases and the significant increased frequency of HLA
antigens (B35, DR4) in patients compared to controls suggest the
possibility of a genetic component. In addition, families with both BD
and Henoch-Schonlein purpura (HSP) have been reported. The alm of
this cooperative study was to gather and study these familial cases in
order to determine the presence of genetic factors. Forty-one families
were studied: 26 with 2 and I with 3 relatives having BD, 10 with 1
patient having BD and a second having HSP, 3 with 2 relatives having
BD and a third with HSP, 1 with 2 relatives having HSP and a third with
BD. Thus, there were 72 BD patients and 15 HSP patients with or
without nephropathy. This study shows: affected members often belong
to the same generation; a frequent interval of several years between the
onsets in a family; male preponderance (BD, 75%; HSP, 53%); frequent
onset before the age of 16 (BD, 50%; HSP, 100%); frequent occurrence
of renal failure (RF) and/or hypertension (BD, 34%, HSP, 13%) or
terminal RF (BD, 19%; HSP, 13%). These familial cases were not
systematically sought and their frequency is underestimated. It is not
exceptional to find nephropathy in a relative, but in the absence of renal
biopsy it cannot be proven that the disease is BD. The multiple
occurrence of cases in a family may be the consequence of common
environmental factors and therefore does not prove the presence of
genetic factors. The use of genetic markers suppresses these environ-
mental correlations. Our results are preliminary (too few families
studied), but there is an excess of HLA-identically affected sibs. These
facts suggest the possibility of some susceptibility gene(s) linked to the
HLA system but do not exclude the role of a large environmental
component and of other genetic factors.
Oven or occult renal amyloidosis in the Muckle-Wells syndrome. G.
Messier, A. Meyrier, M. Rainfray, T. Coste, P. Callard, HOpital
Avicenne, 93000 Bobigny, Hâpital Jean- Verdier, Bondy, France. The
Muckle-Wells syndrome is a rare systemic disease with autosomal
dominant transmission which was described in 1962. Fifteen families
and six sporadic cases have been published. The total number of cases
is now 80 with 39 males and 41 females. The Muckle-Wells syndrome
consists of urtiearia, arthritis, deafness, conjunctivitis and chronic
diarrhea, with or without bouts of abdominal pain, either isolated or in
association. The disease is sometimes complicated with amyloidosis.
We have studied a family of 37, over 4 generations (23 males and 14
females). Reliable data were available in 33 of them. Thirteen (11 males
and 2 females) exhibited the clinical features of the syndrome. One of
them was treated with colchicine which induced frank amelioration of
skin and joint manifestations. Three males had renal amyloidosis which
was proven by percutaneous renal biopsy. Two of them had the
nephrotic syndrome and chronic renal failure; one died after 7 months
of hemodialysis and the other died of lung cancer, In the third, renal
amyloidosis was present on renal biopsy despite negative search for
proteinuria. Renal amyloid was of the AA type. In S patients the
OKT4/OKT8 ratio was determined. It was significantly low (m = 1.34).
Serum complement fractions were normal. Three members of this
family died of malignancy: laryngeal cancer in one, lung cancer in one
and acute leukemia in one. In summary, these findings show that: 1) in
the Muckle-Wells syndrome renal amyloidosis may exist in the absence
of proteinuria; 2) the syndrome seems to entail a derangement of
cell-mediated immunity; and 3) this derangement could explaln the
frequency of amyloidosis and of malignancy observed in our series.
Idiopathic IgA mesangial nepbropathy (Berger's disease) Is the main
cause of end-stage failure (ESRF) in a French area. P. Simon, M. P.
Ramée, K. S. Ang, G. Cam, Department of Nephrology, La BeauchEe
Hospital, Saint-Brieuc, France. Since January 1, 1976, a prospective
study of prevalence (P) and annual incidence (Al) has been performed
in an area of France having 400,000 inhabitants. To December31, 1985,
renal biopsy was indicated in 663 adult (> 15 yrs) patients who were
born and living in the studied area. Primary GN was diagnosed in 418
pts (63%) corresponding to a P for 10 yrs of 1/1000. The results have
been compared for two periods: A (1976 to 1980) and B (1981 to 1985),
for which the number of patients with primary ON was similar (205 vs.
213; Al, 10.3 vs. 10.6/100000). IgA ON (Berger) was the most common
of primary ON (27%) and its Al remained stable for the two periods: 2.6
vs. 3/100000. For the same period under review, 216 ESRF patients
have begun dialysis treatment. Al of ESRF increased between periods
A and B: 4.6 vs. 6.2 pts/100,000; the percentage of undertermined
causes significantly decreased: 16.3% vs. 5.6% (F C 0.01). Among all
patients with primary ON who began dialysis during the period B, 91%
had undergone renal biopsy. Idiopathic IgA ON was the first cause of
ESRF (14%; Al, 0.85/100,000) before diabetes (12%; 0.75/100,000),
polycystic disease (11.3%; 0.70/100,000), focal glomerular sclerosis
(FOS) (10.4%; 0.65/100,000), relfux nephropathy (9.6%; 0.60/100,000).
Theorical P for the evolution of primary ON to ESRF, calculated from
the values of Al for diagnosis and ESRF, was 20.6% for all primary GN,
28.3% for idiopathic IgA ON, 20% for membranoproliferative ON and
only 6.6% for membranous nephropathy. This study demonstrates that
idiopathic IgA mesangial nephropathy was not only the most common
of primary ON but also was the main cause of ESRF in this area of
France.
Hypocitraturia ia calcium nephrolithiasis. M. Daudon, B. Lacour, P.
Houillier, P. Da Costa, R. J. Reveillaud, P. Jun gers, Departments of
Nephrology and Biochemistry, Necker Hospital, 75015 Paris, and
Laboratoire Cristal, 92100 Saint Cloud, France, The prevalence of
hypocitraturia in calcium stone formers is variously evaluated, mainly
due to the different criteria adopted to define the degree and persistence
of this metabolic derangement. Among 309 patients (205 male, 104
female) followed at Necker Hospital between January 1983 and June
1987 with serial determinations of citraturia, 127 (or 41.1%) exhibited at
least once a daily citrate excretion (Ucjt"  320 mg/day (1.66 mmol)
according to Nicar and Pak (Urology 21 :8;l983) most of them having
normal values in other instances. By contrast, only 46(14.8%) exhibited
UV 215 mg/day (1.12 mmol) at least once, according to Rudman
(JGEM 55: 1052;l982) and Jaeger (Schweiz Med Wschr 116:371; 1986).
Using an intermediate threshold based on yalues observed in 60 healthy
controls, a persistent hypocitraturia (UcjtV C 1.5 mmol, or 290 mg/day)
was observed in at least 2 consecutive instances in 52 patients, or
16.8%. In 33 of them, hypocitraturia was associated to either active
urinary tract infection (15), thiazide-induced hypokalemia (15),
hypokalemia from other cause (2) or chronic diarrhea (1). In the other
19 patients, hypocitraturia was apparently idiopathic. It was associated
with hypercalciurin in 6, but presented as an isolated disorder in 13 (8
male, 5 female), i.e., 4.2% of the whole series. Fasting urine pH was 5.8
or more in 11 of 19 patients (all of them having plasma bicarbonates
25 mmol/liter), thus suggesting coexistence of a subtle tubular acidifi-
cation defect. Calculi, avallable in 9 patients, were shown to be made of
calcium oxalate (CaOx) dihydrate in 7 of 9 patients by infrared
spectrophotometry. Crystalluria, examined on first voided morning
urine sample in 16 patients, was absent in 7 and preponderantly made of
CaOx dihydrate crystals in 8 of 9 positive cases with a high proportion
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of large-sized crystals and agglomerates, as observed by others in
hypocitraturic patients (Kok et al, Lancet i: 1056; 1986). We conclude
that mild, intermittent hypocitraturia is frequently observed in patients
with calcium nephrolithiasis, but permanent and isolated marked
hypocitraturia (U1V 1.5 mmollday) is an infrequent disorder, with an
observed prevalence of about 4 percent of patients in our experience.
Supplementation with potassium citrate should be considered for pa-
tients in whom hypocitraturia is confirmed to be a permanent, not only
episodic, metabolic disorder.
Association between relapsing hypertension in pregnancy and lILA
DR4. P. Simon, R. Fauchet, K.S. Ang, M. Pilorge, C. Calvez, B.
Lefiblec, G. Cam, M.C. Laurent, J. Blanchard, B. Genetet, B. Cloup,
Departments ofNephrology and Gynecology-Obstetrics, La Beauchée
Hospital, Saint-Brieuc 22000, Tissue Typing Laboratory, Regional
Blood Bank, University of Rennes Immunology Research Group,
Rennes 35000, France. We studied the frequency of HLA-DR antigens
in 96 women, of whom 50 suffered pre-eclampsia (PE-proteinuria> 0.5
g/liter ÷ HTA) and 46 with gestational HTA (GHTA = pregnancy
induced HTA without proteinuria). Sixty had later pregnancies (28 PB
and 32 GHTA) and were followed for from 3 to 23 years (mean = 8.5
yrs) after the first pregnancy. HLA-DR antigen distribution was deter-
mined by a search on B lymphocytes for the 10 antigens of locus DR.
The normal population included 38 control couples (76 mothers and
fathers) with normotensive pregnancies (A) and 200 healthy controls
recruited from a local blood donor populations (B). The frequency of
alleles was compared to that of the different groups of primiparous
women and whole population of women patients with later pregnancies.
Significant variations were evaluated by the , test, using Woolf s
method; the P value obtained was multiplied by the number of antigens
sought (P corrected or Pc). Only the DR4 antigen, present in 19.7% of
control couples (A) and 26.5% of the blood donor population (B), was
increased in proportions that depended on clinical classification: 54.3%
(Pc <0.005 with A, <0.007 with B) in all primiparous women with
GHTA, and 38% (NS) in all primiparous women with PE. In relapsing
HTA in later pregnancies (61.6% of 60 primiparous women), DR4
antigen was present in 48.6% vs. 8.7% in 23 women without relapsing
HTA (Pc <0.01). In 21 women with chronic HTA (PAD > 95 mm Hg)
in post-partum (> 6 months) DR4 antigen was present in 81% (N 17)
vs. 7.7% (N = 3) in 39 women with normal PA at the end of this study(Pc < 0.001). It is suggested that there may be an immunogenetic
predisposition toward relapsing HTA in pregnancy and developing chronic
HTA in DR4 women who presented pregnancy-induced hypertension.
Hantavirus nephropathy (HVN) in France and Belgium. Epidemiolog-
ical and clinical data. J.Ph. Mery, C. van Ypersele de Strihou, (Hôpital
Bichat, Paris, Cliniques Universitaires St-Luc, Brussels, Belgium. HV
infection, a rodent-borne zoonose, is a recently recognized cause of
acute interstitial nephritis (AIN) in Western Europe. A both retrospec-
tive and prospective survey was conducted in France and Belgium
during the year 1986. Seventy-six cases (males: 84%, mean age 35
years) were collected. The first retrospectively diagnosed cases (9)
occurred in 1977 as a limited epidemic in the north of France; 3 cases
occurred in 1978 among Belgian technicians as a laboratory-associated
infection, whereas the remaining cases, all sporadic, occurred between
1982 and 1986. A seasonal peak (May to June) was observed. After an
incubation of 12 to 20 days, the clinical picture is usually typical with
the sudden onset of a flu-like syndrome with fever which is associated
within a few days with loin pain and, occasionally, with nausea and
vomiting, acute myopia and conjunctival hemorrages. Most of these
signs disappear within a week while urine output decreases and renal
failure is discovered. A transient, often massive, proteinuria associated
with microscopic hematuria occurs at the same time. Thrombocytope-
nia and elevated serum LDH are documented in about 60% of the cases.
Serum creatinine peaked (mean of the peaks: 567 smol/liter) on the
average at day 9. Seven patients were dialyzed. The subsequent course
is benign: renal function returns to normal within 1 or 2 weeks while
clinical and biochemical abnormalities disappear. No mortality was
observed. Renal biopsy (27 cases) showed AIN in most cases; albeit
observed in only few cases, medullary interstitial hemorrages together
with hyperemic peritubular capillaries represent the hallmark of HVN.
IF was negative in all cases. HV infection was serologically proved in
all cases. Titer of antibodies rises within the first 3 weeks of the disease;
definitive persistence of antibodies permits retrospective diagnosis.
Almost all cases were due to the Puumala serotype of HV. In conclu-
sion, HVN appears to be a frequent cause of AIN in Western Europe.
It has a benign course which is similar to the one of Nephropathia
epidemica which was described long ago in Scandinavia and which is
also due to the Puumala virus. In contrast, it is different from the more
severe cases of HV observed in Asia which are due to different
serotypes of HV.
